These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31400612)

  • 1. Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts.
    Shokoohmand A; Ren J; Baldwin J; Atack A; Shafiee A; Theodoropoulos C; Wille ML; Tran PA; Bray LJ; Smith D; Chetty N; Pollock PM; Hutmacher DW; Clements JA; Williams ED; Bock N
    Biomaterials; 2019 Nov; 220():119402. PubMed ID: 31400612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis.
    Elshafae SM; Dirksen WP; Alasonyalilar-Demirer A; Breitbach J; Yuan S; Kantake N; Supsavhad W; Hassan BB; Attia Z; Alstadt LB; Rosol TJ
    Prostate; 2020 Jun; 80(9):698-714. PubMed ID: 32348616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment.
    Reichert JC; Quent VM; Burke LJ; Stansfield SH; Clements JA; Hutmacher DW
    Biomaterials; 2010 Nov; 31(31):7928-36. PubMed ID: 20688384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
    Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
    Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioengineered Microtissue Models of the Human Bone Metastatic Microenvironment: A Novel In Vitro Theranostics Platform for Cancer Research.
    Bock N
    Methods Mol Biol; 2019; 2054():23-57. PubMed ID: 31482446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The secreted matrix protein mindin increases prostate tumor progression and tumor-bone crosstalk via ERK 1/2 regulation.
    Ardura JA; Gutiérrez-Rojas I; Álvarez-Carrión L; Rodríguez-Ramos MR; Pozuelo JM; Alonso V
    Carcinogenesis; 2019 Jul; 40(7):828-839. PubMed ID: 31168562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.
    Raheem O; Kulidjian AA; Wu C; Jeong YB; Yamaguchi T; Smith KM; Goff D; Leu H; Morris SR; Cacalano NA; Masuda K; Jamieson CH; Kane CJ; Jamieson CA
    J Transl Med; 2011 Oct; 9():185. PubMed ID: 22035283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.
    Larson SR; Chin J; Zhang X; Brown LG; Coleman IM; Lakely B; Tenniswood M; Corey E; Nelson PS; Vessella RL; Morrissey C
    Clin Exp Metastasis; 2014 Feb; 31(2):247-56. PubMed ID: 24242705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
    Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer.
    Lin SC; Lee YC; Yu G; Cheng CJ; Zhou X; Chu K; Murshed M; Le NT; Baseler L; Abe JI; Fujiwara K; deCrombrugghe B; Logothetis CJ; Gallick GE; Yu-Lee LY; Maity SN; Lin SH
    Dev Cell; 2017 Jun; 41(5):467-480.e3. PubMed ID: 28586644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.
    Fitzgerald KA; Guo J; Tierney EG; Curtin CM; Malhotra M; Darcy R; O'Brien FJ; O'Driscoll CM
    Biomaterials; 2015 Oct; 66():53-66. PubMed ID: 26196533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer.
    Choudhary S; Ramasundaram P; Dziopa E; Mannion C; Kissin Y; Tricoli L; Albanese C; Lee W; Zilberberg J
    Sci Rep; 2018 Dec; 8(1):17975. PubMed ID: 30568232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer.
    Fradet A; Sorel H; Depalle B; Serre CM; Farlay D; Turtoi A; Bellahcene A; Follet H; Castronovo V; Clézardin P; Bonnelye E
    PLoS One; 2013; 8(9):e75092. PubMed ID: 24069383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.
    Goya M; Ishii G; Miyamoto S; Hasebe T; Nagai K; Yonou H; Hatano T; Ogawa Y; Ochiai A
    Prostate; 2006 Nov; 66(15):1573-84. PubMed ID: 16927388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
    Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
    Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells.
    McGovern JA; Bock N; Shafiee A; Martine LC; Wagner F; Baldwin JG; Landgraf M; Lahr CA; Meinert C; Williams ED; Pollock PM; Denham J; Russell PJ; Risbridger GP; Clements JA; Loessner D; Holzapfel BM; Hutmacher DW
    Commun Biol; 2021 Aug; 4(1):1014. PubMed ID: 34462519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyurethane foam scaffold as in vitro model for breast cancer bone metastasis.
    Angeloni V; Contessi N; De Marco C; Bertoldi S; Tanzi MC; Daidone MG; Farè S
    Acta Biomater; 2017 Nov; 63():306-316. PubMed ID: 28927931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis.
    Sieh S; Taubenberger AV; Lehman ML; Clements JA; Nelson CC; Hutmacher DW
    Bone; 2014 Jun; 63():121-31. PubMed ID: 24530694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
    Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
    Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro bone metastasis dwelling in a 3D bioengineered niche.
    Han W; El Botty R; Montaudon E; Malaquin L; Deschaseaux F; Espagnolle N; Marangoni E; Cottu P; Zalcman G; Parrini MC; Assayag F; Sensebe L; Silberzan P; Vincent-Salomon A; Dutertre G; Roman-Roman S; Descroix S; Camonis J
    Biomaterials; 2021 Feb; 269():120624. PubMed ID: 33421710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.